Physician profile
Jonathan Mark Richards
NPI 1457511362
$1,626.91
in general payments reported to CMS, 2019-2025
27 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $123 · 2021: $19.80 · 2022: $410 · 2023: $391 · 2024: $98.01 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $225.45 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Abiomed | $216.47 | 2023 | Impella |
| Janssen Pharmaceuticals, INC | $168.19 | 2019-2023 | Xarelto |
| Mentor Worldwide LLC | $123.66 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.83 | 2019-2023 | Ofev |
| Ucb, INC. | $96.27 | 2019-2022 | |
| Electromed, INC. | $65.16 | 2024-2025 | Smartvest |
| Portola Pharmaceuticals, LLC | $62.67 | 2019 | |
| Merck Sharp & Dohme LLC | $51.08 | 2019-2022 | |
| United Therapeutics Corporation | $45.31 | 2022 | |
| Chiesi USA, INC. | $42.80 | 2022 | |
| Zimmer Biomet Holdings, INC. | $38.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.46 | 2022 | |
| Paratek Pharmaceuticals, INC. | $33.41 | 2022-2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $31.21 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $30.52 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $29.98 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $28.61 | 2022 | |
| Viatris Specialty LLC | $26.87 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $24.93 | 2019 | |
| Mallinckrodt Hospital Products INC. | $24.77 | 2020 | |
| Coaptech, INC. | $24.62 | 2025 | Puma System |
| Abbott Laboratories | $24.46 | 2023 | 2nd Gen Centrimag Primary Console |
| Inogen, INC. | $17.22 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $16.11 | 2022 | |
| La Jolla Pharmaceutical Company | $15.31 | 2019 | |
| Ambu INC. | $8.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.